Bacterial armour could be a new target for antibiotics
07 August 2018
Attacking the outer membrane of infectious bacteria will weaken them for targeting with antibiotic treatments. Image: Kevin Craft
Boosting efforts to fight antibiotic resistance, Stanford researchers have found that a thin membrane, thought to be just a shrink wrap around some bacterial cell walls, has structural properties critical for survival, writes Tom Abate. Drugs that destroy the membrane could be a new approach to treating infection.
(Video, below, (https://youtu.be/SkGnab0xuUQ) courtesy of Enrique Rojas: This side-by-side comparison reveals a newly discovered defensive mechanism of E. coli, the bacterium that causes food poisoning.)
For more than a century, scientists have studied E. coli, one of the bacteria that cause food poisoning, as a model for fighting infections. Such research has led to a variety of antibiotics that penetrate the protective cell walls of bacteria to kill them.
Now, a multi-university study led by Stanford bioengineer KC Huang reveals that E. coli has managed to keep a big secret about its defences. He and his collaborators report in ‘Nature’ that scientists had overlooked the astonishing physical strength of the thin outer membrane that clings to E. coli’s stout cell wall.
Scientists had long known that many bacteria have outer membranes. But until now researchers thought of it like a layer of shrink wrap that simply made it tougher to get antibiotics into cells. But as the new study shows, the outer membrane physically protects the cell and could be a good target for a new class of antibacterial drugs.
“We’ve discovered that the outer membrane can act as a suit of armour that is actually stronger than the cell wall,” says Huang, an associate professor of bioengineering and of microbiology and immunology. “It’s humbling to think that this function had been hiding in plain sight for all of these years.”
Huang says the findings suggest new infection-fighting strategies for the roughly half of all bacterial species that, like E. coli, have outer membranes. “If we can attack the outer membrane, infectious bacteria will be pre-weakened for targeting with antibiotic treatments that disrupt cells in other ways,” he says.
All bacteria have a cell wall that surrounds and protects the cell’s inner workings. Many decades ago, scientists discovered that E. coli and many other bacteria have an additional layer, called an outer membrane, that surrounds their cell walls.
Since its discovery, this outer membrane has been used as a way to classify bacteria into those that do and do not react to a common staining technique, called a Gram stain. Bacteria with outer membranes do not react to the chemical stain are called Gram-negative. Bacteria with naked cell walls react to the stain and are classified as Gram-positive.
Both kinds of bacteria can become infectious and, when this occurs, the presence or absence of an outer membrane can also help determine how responsive they will be to antibiotics. Gram-negative bacteria – which have outer membranes – tend to be more resistant to antibiotics.
“Scientists knew that outer membranes were chemical shields,” says Huang. “Thus, it was easy to relegate this third layer to an annoyance when dosing the cell with antibiotics.”
In recent years, however, researchers have had clues that the outer membrane is more important than they’d thought. In one study, Huang’s lab removed E. coli’s cell wall but left its outer membrane intact. Unsurprisingly, the bacteria lost their cucumber shape and became blobs. But a large fraction of these blobs survived, multiplied and ultimately regenerated new cucumber-shaped E. coli.
Enrique Rojas, a former postdoctoral scholar in Huang’s lab and first author on the new paper, said that study was a clue that the outer membrane must play important structural and protective roles.
“We just listened to the data. Science is about data, not dogma,” says Rojas, now an assistant professor of biology at New York University.
Over the past four years, working with collaborators from the University of California, San Francisco, and the University of Wisconsin–Madison, the group members tested the outer membrane’s structural powers.
Suddenly collapsed the pressure inside the bacteria
They suddenly collapsed the pressure inside the bacteria, but instead of causing the cell wall to massively shrink, as prevailing assumptions would have predicted, they found that the outer membrane was strong enough to almost entirely maintain E. coli’s cucumber shape.
In other experiments, they put E. coli cells through two hours of rapid increases and decreases in pressure. E. coli cells normally shrug off these repeated insults and grow as if no changes at all had occurred. However, when the researchers weakened the outer membrane, cells died quickly.
“The presence or absence of a strong outer membrane is the difference between life and death,” says Huang.
The experiments identified a handful of components that give the outer membrane its surprising strength. Drugs that destabilise the deceptively thin outer layer could help destroy infectious bacteria, says Huang.
Huang adds that the findings are part of an emerging field of study called mechanobiology. Whereas scientists once viewed cells as sacks of chemicals to be studied by chemical means, today a confluence of tools reveal the infinitely complex structural properties that make cells and organs tick.
“It’s a very exciting time to be studying biology,” says Huang. “We are approaching the point at which our tools and techniques are becoming precise enough to discern, sometimes at almost the atomic level, the physical rules that give rise to life.”
KC Huang is also a member of Stanford Bio-X and a faculty fellow at Stanford ChEM-H. Additional Stanford co-authors include Julie Theriot, a professor of biochemistry and of microbiology and immunology, and a member of Stanford Bio-X; graduate student Amanda Miguel; postdoctoral scholar Pascal Odermatt; and undergraduate Lillian Zhu. Other authors are from the University of Wisconsin–Madison and the University of California, San Francisco.http://www.engineersjournal.ie/2018/08/07/bacterial-armour-new-target-antibiotics/http://www.engineersjournal.ie/wp-content/uploads/2018/08/a-abac-1024x683.jpghttp://www.engineersjournal.ie/wp-content/uploads/2018/08/a-abac-300x300.jpgBiobacteria,diseases,United States